GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Navco Pharmaceuticals Inc (TSXV:NAV) » Definitions » Market Cap

Navco Pharmaceuticals (TSXV:NAV) Market Cap : C$2.00 Mil (As of May. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Navco Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Navco Pharmaceuticals's share price for the quarter that ended in Mar. 2023 was C$0.1. Navco Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 4.60 Mil. Therefore, Navco Pharmaceuticals's market cap for the quarter that ended in Mar. 2023 was C$0.46 Mil.

Navco Pharmaceuticals's quarterly market cap stayed the same from Sep. 2022 (C$0.46 Mil) to Dec. 2022 (C$0.46 Mil) and stayed the same from Dec. 2022 (C$0.46 Mil) to Mar. 2023 (C$0.46 Mil).

Navco Pharmaceuticals's annual market cap declined from Jun. 2019 (C$0.77 Mil) to Jun. 2020 (C$0.45 Mil) but then increased from Jun. 2020 (C$0.45 Mil) to Jun. 2021 (C$0.46 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Navco Pharmaceuticals's Enterprise Value for Today is C$2.27 Mil.


Navco Pharmaceuticals Market Cap Historical Data

The historical data trend for Navco Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navco Pharmaceuticals Market Cap Chart

Navco Pharmaceuticals Annual Data
Trend Jun18 Jun19 Jun20 Jun21
Market Cap
- 0.77 0.45 0.46

Navco Pharmaceuticals Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.46 0.46 0.46 0.46

Competitive Comparison of Navco Pharmaceuticals's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Navco Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navco Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Navco Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Navco Pharmaceuticals's Market Cap falls into.



Navco Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Navco Pharmaceuticals's Market Cap for the fiscal year that ended in Jun. 2021 is calculated as

Market Cap (A: Jun. 2021 )=Share Price (A: Jun. 2021 )*Shares Outstanding (EOP) (A: Jun. 2021 )
=C$0.1*4.6
=C$0.46

Navco Pharmaceuticals's Market Cap for the quarter that ended in Mar. 2023 is calculated as

Market Cap (Q: Mar. 2023 )=Share Price (Q: Mar. 2023 )*Shares Outstanding (EOP) (Q: Mar. 2023 )
=C$0.1*4.6
=C$0.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navco Pharmaceuticals  (TSXV:NAV) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Navco Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Navco Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Navco Pharmaceuticals (TSXV:NAV) Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6E 4N7
Website
Navco Pharmaceuticals Inc uses of nanotechnology to develop and commercialize novel products to protect against viruses, bacteria, and infectious diseases. The company's pipeline of applications is tailored to defend against pathogens utilizing new methods of action to capitalize on unmet product needs using natural & known compounds, nanoparticles, and no chemicals with a high degree of efficacy. Its target markets include human health & personal skin care, household & institutional products, and veterinary health.